Michael Egholm - 20 Aug 2024 Form 4 Insider Report for STANDARD BIOTOOLS INC. (LAB)

Reporting owner
Signature
/s/ Michael Egholm by Agnieszka Gallagher, Attorney-in-Fact
Issuer context
Transaction snapshot
SEC evidence
Form type
4
Filing time
05 Sep 2024, 17:59:09 UTC
Previous filing
21 May 2024
Next filing
21 Nov 2024
SEC filing
View on sec.gov

Key filing fact

Michael Egholm filed Form 4 for STANDARD BIOTOOLS INC. (LAB) on 05 Sep 2024.

Key facts

  • This page summarizes Michael Egholm's Form 4 filing for STANDARD BIOTOOLS INC. (LAB).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Filing timestamp: 05 Sep 2024, 17:59.

Change

  • Previous filing in this sequence was filed on 21 May 2024.
  • Current net transaction value: -$55,568.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reported transactions

LAB transaction

Common Stock

Tax liability

Transaction value
$55,568
Shares
-29,093
Change %
-1.9%
Price
$1.91
Shares after
1,502,499
Date
20 Aug 2024
Ownership
Direct
Footnotes
F1
* indicates a reported price that failed the local validity check.

Explanation of Responses:

Id Content
F1 The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on May 20, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on May 21, 2024.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .